Junqing Wang

6PUBLICATIONS
11CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 12, 2025
Stratification of Hepatocellular Carcinoma Using N6-Methyladenosine.

Nan Wang, Jia-Xin Shi, Matthias Bartneck

|Mar 21, 2025
Ascending E2F7a/b ratio facilitates KLF13 transcription in hepatocellular carcinoma and correlates with the abundance of binuclear hepatocytes (ABH) modulation for short-term recurrence.

Yian Zhang, Yiquan Lu, Nan Wang

|Feb 27, 2024
Alternative splicing-related long noncoding RNA ANRIL facilitates hepatocellular carcinoma by targeting the miR-199a-5p/SRSF1 axis and impacting Anillin.

Yifan Zhang, Yiquan Lu, Nan Wang

|Oct 26, 2023
Attenuation of binuclear hepatocytes in the paracancerous liver tissue is associated with short-term recurrence of hepatocellular carcinoma post-radical surgery.

Yifan Zhang, Nan Wang, Fengjie Hao

|Aug 04, 2022
E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA-383-5p transcription.

Fengjie Hao, Nan Wang, Yifan Zhang

|Jul 25, 2018
Biostatistics mining associated method identifies AKR1B10 enhancing hepatocellular carcinoma cell growth and degenerated by miR-383-5p.

Junqing Wang, Yunyun Zhou, Xiaochun Fei

Pageof 1

Frequent Collaborators

3 joint publications

Nan Wang

2 joint publications

Fengjie Hao

2 joint publications

Xiaochun Fei

1 joint publications

Yifan Zhang